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Iron plays a crucial role in multiple physiological functions and is essential for human health 
and physical performance, particularly for athletes or military personnel, whose iron 
requirements may be higher due to factors including increased erythropoietic drive, footstrike 
hemolysis, menses, gastro-intestinal bleeding, exercise-induced inflammation, anti-
inflammatory drug use and environmental stress. Investigations into the effects of strenuous 
physical activity on iron status have predominantly concentrated on females but in this Acta 
Haematologica issue, Epstein et al. describe the development of iron deficiency (ID) and iron 
deficiency anemia (IDA) in male soldiers. Prevalence of ID and IDA in recruited males was 
unexpectedly high and increased significantly following the first six months of training, 
attributed to the continuous physical training[1]. Whilst there is broad awareness of the of ID 
in females, the evidence reported by Epstein et al. show males undertaking arduous military 
training are also vulnerable to ID and  attention should be paid to hematological monitoring 
and nutritional status of male soldiers and athletes to ensure the detrimental effects of iron 
deficiency are recognized and treated appropriately.  
 
Prevalence data of ID and IDA is influenced by the diagnostic criteria applied. Epstein et al. 
use cut-off values <14 g/dl for hemoglobin concentration ([Hb]) and <30 μg.L-1 for serum 
ferritin (sFer) to define ID and IDA and they acknowledge that this definition is in contrast to 
much of the literature. Correctly diagnosing and treating iron deficiency in athletes is a 
challenge due to: 1. The absence of a clear definition; 2. The absence of a clear treatment 
and monitoring protocol, particularly if the iron deficiency is not accompanied by anemia (iron 
deficiency non anemia; IDNA); 3. Training induced plasma volume expansion. Furthermore, 
sFer is the most commonly used indicator of iron status but sFer criteria vary throughout the 
literature, ranging from 12-40 μg.L-1 [2], whereas in clinical investigations of inflammatory 
diseases a sFer <100 μg.L-1 might be viewed as ID. The acute phase response of sFer adds 
further complication, as exercise or illness can cause variation in sFer levels, potentially 
masking the true value. 
Epstein et al. and Kell & Pretorius (2014) question the use of sFer for monitoring the iron 
status of individuals who undergo physical training. Traditionally, sFer is used as an indicator 
of whole body iron status based on tissue ferritin correlating strongly with iron stores, 
however, sFer lacks most of the iron it contained in its intracellular form. A more 
contemporary understanding of sFer is as a marker of inflammation and cell death[3].  
Alternative markers are needed. Epstein et al. suggest that transferrin saturation (TSat) and 
transferrin receptor (sTfR) are useful additions to sFer. Although Tsat can be influenced 
by inflammation, sTfR is not an acute phase protein. Total hemoglobin mass (tHb-Mass) 
measured by carbon monoxide rebreathing has also been used to assess the effectiveness 
of iron treatments[4]. Complete blood cell count (CBC) indices assessed alongside [Hb], 
sFer and Tsat, inform the impact that ID and IDA may be having on reticulocyte and 
erythrocyte populations. These measurements remain stable in healthy individuals but 
marked alterations occur in chronic disease states [5]. However, unlike IDA, CBC indices 
remain unchanged in IDNA, leaving the understanding of this condition largely incomplete. 
Hepcidin, a peptide hormone that regulates iron absorption shows promise as a key marker 
of iron status and the influence of strenuous physical activity on hepcidin should be a target 
of future research. The regulation of hepcidin is mediated by multiple stimuli, including iron 
status, inflammation and hypoxia, which are relevant to soldiers and athletes. Longitudinal 
measurements of acute and chronic exercise exposure together with these biomarker 
variables would further our understanding of how physical training may affect iron 
absorption.  
Currently, ID can only be confirmed by a positive response to treatment, in the form of an 
increase in tHb-Mass, however, this retrospective approach still does not allow practitioners 
to be proactive in the identification and treatment of conditions related to ID.  Given that the 
utility of traditional methods of assessing ID, particularly IDNA, do not provide a definitive 
insight into the condition it is perhaps time to seek an alternative. Recently, a model has 
been developed which characterizes the birth rate, maturation and clearance dynamics of 
red cell populations using raw data from automated hemoanalysers that report single 
reticulocyte and erythrocyte volume and hemoglobin measurements[6]. Using clinical patient 
groups Higgins and Mahadevan (2010) have identified patients with anemia and 
distinguished thalassemia-trait anemia from IDA. The model has also identified pre-anemic 
states several weeks before anemia has become clinically detectable. This research is 
based on clinical populations but the findings could have important implications in athletic 
settings. Early identification of iron deficient states would be significant in the support of the 
health, wellbeing and performance of military personnel and athletes. It is time for iron 
deficiency research to look beyond ferritin. 
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